Antioxidant level in normal and dialyzed patients using frap method

Pakistan Journal of Pharmaceutical Sciences

Volumn 23, Issue 2, 2010, Pages 175-177

  Mustafa, Ghulam ^a   Khalid Khan, Ikram Ullah Khan M ^a   Sualeh, Mohammad ^b  

^a GOMAL UNIVERSITY   (Pakistan)

^b FEDERAL URDU UNIVERSITY OF ARTS   (Pakistan)

Author keywords

FRAP (Ferric Reducing Ability of Plasma); GSH (Glutathione); TAC (Total Antioxidant Capacity)

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CREATININE; FREE RADICAL; GLUTATHIONE; UREA;

ADULT; AGED; ANALYTIC METHOD; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FERRIC REDUCING ABILITY OF PLASMA METHOD; HEMODIALYSIS PATIENT; HUMAN; KIDNEY CLEARANCE; KIDNEY DISEASE; MALE; OXIDATIVE STRESS; PATHOGENESIS; UREA BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; ASCORBIC ACID; BLOOD CHEMICAL ANALYSIS; CREATININE; GLUTATHIONE; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; UREA; VITAMIN E;

EID: 77951751799     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bartoz G (2003). Total antioxidant capacity. Adv. Clin. Chem., 37: 219-292.
2. Benkovic V, OrsolicN, Knezevic AH, Ramic S, Dikic D, Basic I and Kopjar N (2008). Evaluation of the radioprotective effects of propolis and flavonoids in gamma-irradiated mice: the alkaline comet assay study. Bid. Pharm. Bull., 31(1): 167-172
3. Boham V, Tthroke K, Scacider S, Sperschneider H, Stein G and Bistsch R (1997). Vitamin C status of patients with chronic renal failure,dialysis patient and patients after renal transplantation. Int. J. Vitamin Nutr. Res., 67(4): 262-266. (Pubitemid 27369706)
4. Cao G and Prior RL (1999). Measurement of oxygen related absorbance capacity in biological sample. Methods Enzmol., 299: 50-62 (Pubitemid 28483881)
5. Cristol JP, Canauld B, Rahesan Dratana H and Gaillard I (1994). Enhancement of reactive oxygen species production and cell surface makers expression. Heamodialysis, 2( 9): 389-394.
6. Cross H, de Azevedo MJ, Silveiro SP and Canani H (2005). Diabetic nephropathy: Diagnosis, Prevention and treatment. Diabetes Care, 28(1): 164-177.
7. Halliwell B (1994). Free radicals, antioxidants and human diseases curicity, cause or consequence. Lancet, 344(8924): 721-724.
8. Hegbrant J, Hult V. and Begsson V (1999). Vitamin C and E as antioxidants in hemdialysis patients. Int. J. Artif. Organs., 22: 69-73.
9. Jensen, T, Stender, S and Deckert, T (1988). Abnormalities in plasma concentration of lipoprotein and filingen in type I (insulin dependent) diabetes patients with increased urinary albumin excertion. Daibetologia, 31: 142-145.
10. Jensen T, Poorch-Jolinsen K, Kafeed Enevoldsen A and Declcert T (1987). Coronary heart disease in young type I (insulin-dependent) diabetic patients with and with out dialetic nephropethic incidence and risk factors. Diabetologia, 30: 144-148. (Pubitemid 17056998)
11. Jee SH, Kin HJ and Lee (2005). Obesity insulin resistance and cancer risk. Yonsci. Med. J., 46: 449-455.
12. Nakai S, Shinzato T, Nagura Y, Masakene J, Kitaoka T, Shinod T, Yamazakic, Sakai R, Morita O and Iseki K (2005). An overview of regular dialysis treatment in Japan as of 31 Dec 2003. Ther. Apher. Dial., 9: 431-458.